Olanzapine 10 mg/2mL (Olanzapine INJECTION, POWDER, FOR SOLUTION) 10 mg/2mL

Olanzapine 10 mg/2mL injection is a powder for solution used for managing certain mental health conditions. This intramuscular formulation is manufactured by Sandoz Inc in the USA.

Strength

10 mg/2mL

Pack Size

1 VIAL in 1 CARTON (0781-3159-72) / 2 mL in 1 VIAL

Manufacturer / TM Owner

Sandoz Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Olanzapine 10 mg/2mL is typically used to manage symptoms of schizophrenia and bipolar disorder. It works by affecting the balance of natural substances in the brain. This medication is often prescribed when oral administration is not feasible or practical.

Side Effects

Common effects of Olanzapine 10 mg/2mL may include drowsiness, dizziness, weight gain, and dry mouth. Some users may also experience mild headaches or constipation. These effects can vary widely among individuals.

Precautions & Warnings

Olanzapine 10 mg/2mL should be handled with care, ensuring proper storage and preparation. It is important to follow healthcare provider instructions for administration. This medication may cause drowsiness, so caution is advised when operating machinery or driving.

Avoid Interactions

Olanzapine 10 mg/2mL may interact with alcohol, other antidepressants, and certain pain medications. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Always consult a healthcare professional before starting any new medication.

Frequently Asked Questions

Olanzapine 10 mg/2mL is used to manage symptoms of schizophrenia and bipolar disorder when oral administration is not feasible.

Olanzapine 10 mg/2mL is administered as an intramuscular injection after reconstitution of the powder.

Common side effects may include drowsiness, dizziness, weight gain, and dry mouth.

Olanzapine 10 mg/2mL may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

If you miss a dose, consult your healthcare provider for guidance on when to administer the next dose.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.